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ABSTRACT
The aim of this study is to investigate the expression of adenosine 3',5'-cyclic monophosphate (cAMP) and 
cAMP-response element-binding protein (CREB) in the human penis as it is known that luteinizing hor-
mone (LH) regulates cellular function mostly through the cAMP signaling pathway and LH receptors are 
expressed by the penile endothelium. Penile tissue was obtained from three patients during partial or total 
penectomy due to a rectal cancer with secondary penile metastasis or squamous cell carcinoma of the penis. 
Immunohistochemistry was used for the detection of cAMP and CREB. Positive immunoreaction for 
cAMP was present in most cells of superficial, intermedial, and basal layer of urethral epithelium and in 
fibroblast-like cells (FLC) of interstitial tissue and endothelial cells (EC) of cavernous spaces in corpus 
spongiosum penis. Positive staining for cAMP was also visible in EC of cavernous spaces and in FLC of 
interstitial tissue in corpus cavernosum penis. Positive immunoreaction for CREB was present in the super-
ficial and intermedial layer of urethral epithelium, and some positive immunoreaction was also noticed in 
EC of cavernous spaces and in FLC of interstitial tissue in corpus spongiosum penis. Positive staining was 
also visible in the EC of cavernous spaces and in fibroplast-like cells of the interstitial tissue in the corpus 
cavernosum penis. Our results show the presence of cAMP and CREB in the human penis. While LH exerts 
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INTRODUCTION
Human luteinizing hormone (hLH) and human 
chorionic gonadotropin (hCG) are heterodimeric 
glycoproteins, consisting of a common α-subunit 
noncovalently associated with a hormone-specific 
β-subunit. Both hormones act via human luteiniz-
ing hormone receptor (hLHR).1
Extracellular messengers, which cannot pass 
the cell membrane, translate the signals from the 
plasma membrane to intracellular second messen-
gers via ligand-binding-induded conformation 
changes in the intracellular parts of the cell surface 
receptors. The cyclic adenosinemonophosphate 
(cAMP) is the most important cyclic phosphate 
related to signal transduction. Synthesized from 
the adenosine triphosphate by the adenylate 
cyclase, cAMP mostly mediates its effects by 
cAMP-dependent protein kinase A (PKA).2
By binding to its receptor, LH leads to an 
increase in the intracellular cAMP level.3 On 
Leydig cells, LH binds to its G-protein-coupled 
receptor and activates adenylate cyclase, which 
triggers an increase in cAMP levels from the 
intracellular adenosine triphosphate reserve and 
expression of the steroidogenic acute regula-
tory  (STAR) protein, which is important for 
the   initiation of steroidogenesis. Steroidogenesis 
decreases passively by the degradation of cAMP 
into AMP by phosphodiesterase 4, 8A, and 8B.4
In the ovary, both follicle stimulating hormone 
(FSH) and LH stimulate adenylate cyclase activity, 
cAMP production, and thereby activation of PKA. 
Apart from its cytoplasmic effects, PKA translo-
cates to the nucleus and regulates gene expression 
by phosphorylating transcription factors, especially 
cAMP-response element-binding protein (CREB). 
CREB phosphorylation by PKA leads to its inter-
action with other nuclear regulatory proteins to ini-
tiate transcription of cAMP-responsive genes.5
CREB is known as a transcription factor that 
participates in growth factor-dependent cell sur-
vival, glucose homeostasis, proliferation, and 
memory. CREB belongs to the CREB/ATF-1 
(activating transcription factor 1)/CREM (CRE 
modulator) transcription factor family, eliciting 
responses to a variety of signals, including growth 
factor and stress.6
It has been previously shown that luteiniz-
ing  hormone/choriogonadotropin receptor 
(LHCGR) is present in the mouse and human 
penis.7,8 It is not known what functions LHCGR 
may have in the penis, but it is possible that age- 
associated increased LH levels9 may directly affect 
penile tissue and thereby play a crucial role in the 
development of erectile disorders. While LH 
exerts its actions through cAMP signaling sys-
tem, our study shows that cAMP and CREB are 
present in the human penis tissue.
MATERIALS AND METHODS
Penile tissue was obtained from three patients 
treated at the Tampere University Hospital. The 
patients were undergoing partial or total penec-
tomy either due to squamous cell carcinoma of 
the penis or due to rectal cancer.
One 83-year-old patient with squamous cell 
carcinoma of the penis was undergoing partial 
penectomy. Two patients aged 66 and 64 years 
were undergoing total penectomy due to rectal 
cancer with secondary penile metastasis.
its actions through cAMP signaling system and our previous studies have shown the expression of lutein-
izing hormone/choriogonadotropin (LHCG) receptor in the mouse and human penis, this finding may 
support the hypothesis that LH could affect the spongious and cavernous tissue of the human penis and 
thereby influence the development of erectile dysfunction among aging men.
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Samples from corpus cavernosum and corpus 
spongiosum penis were fixed in 4% formalin over-
night at 4°C. After fixation, the samples were stored 
in 70% ethanol until embedding in paraffin.
Immunohistochemistry
Samples from corpus cavernosum and corpus 
spongiosum of penis were embedded in paraffin 
after fixation in formalin. The 5 µm sections were 
cut, deparaffinized, and treated with 0.9% H2O2 to 
inactivate endogenous peroxidase. The sections were 
then treated with Dako REAL Antibody Diluent 
(S2022; Dako Denmark A/S, Glostrup, Denmark) 
to block nonspecific binding. After blocking, the 
sections were incubated with the mouse monoclonal 
antibody to cAMP (ab24851, Abcam) or rabbit 
monoclonal antibody to CREB (ab32096, Abcam) 
overnight at 4°C. Primary antibody dilution was 
1:200. Visualization of the primary antibody was 
performed using the commercial kit “Dako REAL™ 
EnVision™ Detection System, Peroxidase/DAB+, 
Rabbit/Mouse” (K5007; Dako Denmark A/S, 
Glostrup, Denmark). Washing steps in-between 
were done in phosphate-buffered saline (PBS) which 
contained 0.07% of Tween 20 as the detergent. 
Toluidine blue (Applichem, Darmstadt, Germany) 
was used for background staining. No immunohis-
tochemical staining was noted in negative controls 
where the primary antibody was omitted.
RESULTS
Positive immunoreaction for cAMP was pres-
ent in most cells of superficial (ESL), intermedial 
(EIL), and basal layer (EBL) of urethral epithe-
lium and in fibroblast-like cells of interstitial tissue 
(FLC) and endothelial cells of cavernous spaces 
(EC) in corpus spongiosum penis (Figure 1a).
Positive staining for cAMP was also visible in 
EC of cavernous spaces and in FLC of interstitial 
tissue in corpus cavernosum penis (Figure 1b).
Positive immunoreaction for CREB was pres-
ent in superficial (ESL) and intermedial layer 
(EIL) of urethral epithelium, and some positive 
staining was also noticed in EC of cavernous 
spaces and in FLC of interstitial tissue in corpus 
spongiosum penis (Figure 2a). Positive staining 
was also visible in EC of cavernous spaces and in 
FLC of interstitial tissue in corpus cavernosum 
penis (Figure 2b).
a b
FIG. 1  Expression of cAMP in the human penis. Positive cells are pointed by arrows. Positive 
immunoreaction is present in most cells of superficial (ESL), intermedial (EIL), and basal layer 
(EBL) of urethral epithelium, in fibroblast-like cells of interstitial tissue (FLC) and endothelial cells 
of cavernous spaces (EC) in corpus spongiosum penis (a). Note positive staining for cAMP also in 
EC of cavernous spaces and in FLC of interstitial tissue in corpus cavernosum penis (b).
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No positive cells were visible in negative con-
trols (Figure 3).
DISCUSSION
The present study shows first time positive immu-
noreaction for cAMP and CREB in human penis 
tissue. This knowledge, together with our earlier 
finding on LH expression in the mouse7 and human8 
penile endothelium, would indicate that LH has yet 
an unknown role in the human penis. It is possible 
that the elevated LH levels could regulate the penile 
tissue of the aging men so that the erectile mecha-
nisms do not function properly. The potential 
actions of LH in the human penis are supported by 
the present observations that two components of 
the adenylate cyclase signal transduction pathway 
used by the LH receptor, cAMP and CREB, are 
present in the human penile endothelium.
As the expression of PKA in the human penile 
arteries has been demonstrated before and on the 
basis of the figures presented by Waldkirch et al.,10 
and the EC—when compared with the controls 
given—would seem to express PKA, the present 
results on the presence of cAMP and CREB in the 
penile tissue, especially the EC, significantly add to 
the understanding of the role of the signal trans-
duction from the LH receptor to the nucleus in the 
penile endothelial cell function. However, as in the 
rat model erectile function and expression levels of 
cAMP were previously shown to be significantly 
lower in the aged than in the younger,11 the present 
results would further support the role of 
a b
FIG. 2  Expression of CREB in the human penis. Note positive immunoreaction for CREB in 
superficial (ESL) and intermedial layer (EIL) of urethral epithelium. Some positive staining is visible 
in endothelial cells of cavernous spaces (EC) and in fibroblast-like cells of interstitial tissue (FLC) 
in corpus spongiosum penis (a). Positive immunoreaction is also present in EC of cavernous spaces 
and in FLC of interstitial tissue in corpus cavernosum penis (b).
FIG. 3  Negative control. No positive cells were 
present in negative controls.
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cAMP–CREB pathway in regulation of the erec-
tile function, but by a new mechanism. If the age 
itself decreases cAMP levels in the penile tissue,11 
the increased LH serum concentrations of the 
aging men may act as a compensatory mechanism 
to again increase the levels of cAMP in the penile 
EC and possibly further to improve the erections.
It is well known that erectile dysfunction is 
related with many comorbidities and lifestyle factors 
and that it is a frequent problem among the aging 
men.12 According to a prognosis made in 1999, by 
2025 roughly 322 million men would be affected by 
erectile dysfunction worldwide.13 Many reasons are 
involved, but the present results suggest that any 
drug or chemical decreasing the penile endothelial 
cAMP levels or lowering the serum LH concentra-
tions could possibly cause potency disturbances.
If  the decrease in cAMP levels in the penile 
tissue reported by Cui et al.11 is due to various 
genetically regulated aging processes in the 
penile cells or due to environmental factors and 
if  the age-associated increased LH levels func-
tion as a compensatory mechanism to maintain 
the erectile capacity, then possibly treatment of 
the impotent men with hCG instead of  testos-
terone should be considered. However, further 
studies are needed to evaluate this possibility.
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